The unmet need in DLBCL
What are the alternatives to R-CHOP in diffuse large B-cell lymphoma?
Negative-data clinical trials in lymphoma presented at ASH 2015
Update on the clinical management of diffuse large B-cell lymphoma
Christian Gisselbrecht et al.
Updates from a Phase I clinical trial examining ublituximab in combination with TGR-1202